Prince Harry appeared in a surprise video for the 2025 WellChild Awards on Tuesday, Jan. 28, and asked people to submit ...

GSK PLC GSK shares advanced 3.35% to £14.02 Monday, on what proved to be an all-around great trading session for the stock ...

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services faces Senate scrutiny due to his ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...